Hoyoung Huh
CIK 1401267 · Chairman, Scientific Adv. Bd. · last filed 2026-06-12
Hoyoung Huh is a Chairman, Scientific Adv. Bd. who has filed 55 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for PLRX, was dated Jun 12, 2026. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.58M
7
55
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PLRX | Director | 239,619 | $1.07 | $256.4K | $0 | 7 | 2026-06-12 |
| AKTX | Director | 120,132 | $8.43 | $1.01M | $0 | 3 | 2025-12-18 |
| Eidos Therapeutics, Inc. (EIDX) Delisted | Director | — | — | — | $0 | 1 | 2018-06-22 |
| CTMX | Director | — | $3.22 | — | $0 | 3 | 2018-06-15 |
| GERN | Director | 154,301 | $1.45 | $223.7K | $0 | 19 | 2018-05-17 |
| FACT | Director | 8,333 | $10.67 | $88.9K | $0 | 1 | 2009-09-09 |
| NKTR | Chief Operating Officer | — | $70.77 | — | $0 | 6 | 2008-12-04 |
Recent Filings
55 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-12 | PLRX | Grant (A) | — | $0 | EDGAR |
| 2025-12-18 | AKTX | Buy (P) | — | $0 | EDGAR |
| 2025-06-09 | PLRX | Grant (A) | — | $0 | EDGAR |
| 2025-03-24 | AKTX | Grant (A) | — | $0 | EDGAR |
| 2025-03-10 | AKTX | Grant (A) | +892,857 | $1000.0K | EDGAR |
| 2024-11-18 | — | Mixed | −8,755,682 | $0 | |
| 2024-06-17 | PLRX | Grant (A) | — | $0 | EDGAR |
| 2023-09-25 | — | Buy (P) | +45,000 | $0 | |
| 2023-09-21 | — | Buy (P) | +80,000 | $0 | |
| 2023-09-19 | — | Buy (P) | +25,000 | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.